Clinical Research: Phase 1 - Phase 4
A Vast Unmet Need: Challenges in Alzheimer’s Disease Clinical Trials
Understanding the obstacles inherent in Alzheimer’s clinical trials, from high screen failure rates to lengthy trial durations that are demanding for both patients and caregivers, can help sponsors plan for – and overcome – these challenges. Despite intensive research, nearly 15 years have passed since the lastnew Alzheimer’s disease medication was approved. For those living...